About Anavasi Diagnostics
Anavasi Diagnostics is a company based in Seattle (United States) founded in 2020 by Minh Duong, Robert Atkinson, and Barry Lutz. Anavasi Diagnostics has raised $6 million across 2 funding rounds from investors including NIH. Anavasi Diagnostics offers products and services including AscencioDx Molecular Detector and AscencioDx Covid-19 Test. Anavasi Diagnostics operates in a competitive market with competitors including Alveo Technologies, Luas Diagnostics, VIRIS Detection Systems, BioHermes and DxLab, among others.
- Headquarter Seattle, United States
- Founders Minh Duong, Robert Atkinson, Barry Lutz
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website anavasidx.com
- Social LinkedIn X Facebook Instagram
- Total Equity Funding$6M (USD)
in 2 rounds
- Latest Funding Round$14.9M (USD), Grant
Nov 2021
- Investors
Products & Services of Anavasi Diagnostics
Anavasi Diagnostics offers a comprehensive portfolio of products and services, including AscencioDx Molecular Detector and AscencioDx Covid-19 Test.
Rapid portable tool for detecting SARS-CoV-2 in point-of-care settings.
Nucleic acid detection kit for SARS-CoV-2 variants in medical environments.
Funding Insights of Anavasi Diagnostics
Anavasi Diagnostics has successfully raised a total of $6M across 2 strategic funding rounds. The most recent funding activity was a Grant round of $14.9 million completed in November 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $6M
- Total Rounds 2
- Last Round Grant — $14.9M
- First Round $6M
(Nov 2021)
- Investors Count 1
All 2 funding rounds of Anavasi Diagnostics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2021 | $14.9M | Grant | – | – | |
| Nov 2021 | $6M | Angel Round | – | – | – |
1 investors in total: 1 institutional.
Investors in Anavasi Diagnostics
Anavasi Diagnostics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include NIH.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Drug discovery services are provided to the biopharma sector. | 1887 | nih.gov | United States |
Investor details for Anavasi Diagnostics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Anavasi Diagnostics
11 people are tracked at Anavasi Diagnostics (6 in leadership, 2 in board & advisors, 3 in team).
| Name | Role | Group |
|---|---|---|
Minh Duong | Co-Founder | Leadership |
Robert Atkinson | Co-Founder | Leadership |
Barry Lutz | Co-Founder & CSO | Leadership |
Todd Hallstrom | National Accounts Director | Leadership |
Debra Patterson | VP, Regulatory Affairs | Leadership |
George Stone | Director of Quality | Leadership |
Bryan Crane | Director | Board & advisors |
Arthur Kirsch | Director | Board & advisors |
Patricia K. Atkinson | Controller | Team |
Christine Campbell | Senior Project Manager | Team |
Jim Snow | Purchasing & Supply Management Lead | Team |
Complete people profiles for Anavasi Diagnostics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Anavasi Diagnostics
2 dated milestones of Anavasi Diagnostics across 1 years, from founding to its latest funding, stage changes and deals.
- Founded Anavasi Diagnostics is founded.
- Funding First funding round of $6.0M.
Competitors of Anavasi Diagnostics
Anavasi Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Alveo Technologies, Luas Diagnostics, VIRIS Detection Systems, BioHermes and DxLab, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| alveotechnologies.com | 2014 | Alameda, United States | $63.61M | – | Cloud-powered POC MDx device | |
| luasdiagnostics.com | 2020 | Guildford, United Kingdom | $949,082 | 3 | Sensors and connected app are developed for diabetes management. | |
| virisdetectionsystems.com | 2020 | Denver, United States | – | – | CRISPR-based RNA-guided diagnostics for SARS-CoV-2 detection are developed. | |
| biohermes.com | 2007 | Wuxi, China | – | – | Provider of POC diagnostic devices and kits | |
| dxlab.bio | 2020 | Somerville, United States | – | – | Point-of-care devices for infectious disease detection are developed. | |
| oxsed.com | 2020 | United Kingdom | – | 9 | Diagnostics solutions for COVID-19 infections are provided using RT-LAMP technology. | |
| equinebiotech.org | 2023 | Bengaluru, India | – | – | Provides comprehensive diagnostic test kits for detecting infectious diseases. |
Detailed competitors of Anavasi Diagnostics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Anavasi Diagnostics
Complete news archive for Anavasi Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Anavasi Diagnostics
10 companies that operate in the same segment as Anavasi Diagnostics (Infectious Diseases), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 | |
Therapeutics for drug-resistant bacterial infections are developed. | 2013 | Cambridge, Massachusetts, United States | USD 114.7 M | USD 59.62 M | 32 | |
Clinical diagnostics and drug discovery for immune diseases are provided. | 2009 | Seattle, Washington, United States | USD 419.15 M | USD 276.98 M | 619 | |
Vaccines for infectious diseases are developed using cell-free protein synthesis. | 2013 | Foster City, California, United States | USD 347 M | – | 414 | |
Portable PCR diagnostics for infectious diseases are developed. | 2010 | San Jose, California, United States | USD 386.33 M | – | – | |
Developing glucan synthase inhibitors for the treatment of fungal infections. | 1999 | Jersey City, New Jersey, United States | USD 62.65 M | USD 20.6 M | 28 | |
Sherlock Biosciences is focused on molecular diagnostics development. | 2019 | Watertown, United States | USD 111 M | – | 33 | |
Provider of diagnostic solutions for systemic infections | 2016 | San Francisco, California, United States | USD 191.47 M | – | 54 | |
Developer of novel protein-based therapeutics using machine learning and biological engineering | 2018 | Somerville, Massachusetts, United States | USD 693 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Anavasi Diagnostics
Anavasi Diagnostics was founded in 2020 and raised its 1st funding round 1 year after it was founded.
Anavasi Diagnostics is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.
Anavasi Diagnostics is a funded company, having raised a total of $6M across 2 funding rounds to date. The company's 1st funding round was a Grant of $14.9M, raised on Nov 2021.
Anavasi Diagnostics was established in 2020 in Seattle, United States. Operations are centered in the diagnostics sector, with molecular detectors for COVID-19 produced as the primary focus. The company is led by co-founders Minh Duong, Robert Atkinson, and Barry Lutz, who also serves as chief scientific officer. Development and manufacturing of these diagnostic tools occur within the biotechnology field, targeting infectious disease testing needs in the region.
Anavasi Diagnostics's top competitors include Alveo Technologies, DxLab and BioHermes.
Anavasi Diagnostics offers AscencioDx Molecular Detector and AscencioDx Covid-19 Test.
Anavasi Diagnostics has 1 investor. Key investors include NIH.